Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
Mateusz Stoszko, Elisa De Crignis, Casper Rokx, et al.
EBioMedicine (2015) Vol. 3, pp. 108-121
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

HIV “shock and kill” therapy: In need of revision
Erik Abner, Albert Jordan
Antiviral Research (2019) Vol. 166, pp. 19-34
Closed Access | Times Cited: 142
Transcription: Insights From the HIV-1 Promoter
Enrico Ne, Robert‐Jan Palstra, Tokameh Mahmoudi
International review of cell and molecular biology (2017), pp. 191-243
Closed Access | Times Cited: 65
Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
Chuan Li, Guillaume Mousseau, Susana T. Valente
Epigenetics & Chromatin (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 61
Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir
Shringar Rao, Cynthia Lungu, Raquel Crespo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 46
A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other “Shock” Drugs
Erik Abner, Mateusz Stoszko, Lei Zeng, et al.
Journal of Virology (2018) Vol. 92, Iss. 10
Open Access | Times Cited: 52
Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency Reversal
Christine Marian, Mateusz Stoszko, Lili Wang, et al.
Cell chemical biology (2018) Vol. 25, Iss. 12, pp. 1443-1455.e14
Open Access | Times Cited: 48
HIV-1 Proviral Transcription and Latency in the New Era
Ashutosh Shukla, Nora-Guadalupe P. Ramirez, Iván D’Orso
Viruses (2020) Vol. 12, Iss. 5, pp. 555-555
Open Access | Times Cited: 40
Harnessing Epigenetics: Innovative Approaches in Diagnosing and Combating Viral Acute Respiratory Infections
Ankita Saha, Anirban Ganguly, Anoop Kumar, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 129-129
Open Access
Development of a Diagnostic Model for Focal Segmental Glomerulosclerosis: Integrating Machine Learning on Activated Pathways and Clinical Validation
Yating Ge, Xue-qi Liu, Jinlian Shu, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 1127-1142
Open Access
Chromatin Regulation and the Histone Code in HIV Latency
.
Anne‐Marie W. Turner, David M. Margolis
PubMed (2017) Vol. 90, Iss. 2, pp. 229-243
Closed Access | Times Cited: 44
T cell toxicity of HIV latency reversing agents
Manzhi Zhao, Elisa De Crignis, Casper Rokx, et al.
Pharmacological Research (2018) Vol. 139, pp. 524-534
Closed Access | Times Cited: 41
Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors
Sonia Mediouni, Shuang Lyu, Susan M. Schader, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1980-1980
Open Access | Times Cited: 19
Natural product-derived compounds in HIV suppression, remission, and eradication strategies
Raymond J. Andersen, Fidele Ntie‐Kang, Ian Tietjen
Antiviral Research (2018) Vol. 158, pp. 63-77
Closed Access | Times Cited: 35
A broad drug arsenal to attack a strenuous latent HIV reservoir
Mateusz Stoszko, Enrico Ne, Erik Abner, et al.
Current Opinion in Virology (2019) Vol. 38, pp. 37-53
Open Access | Times Cited: 34
Control of Stimulus-Dependent Responses in Macrophages by SWI/SNF Chromatin Remodeling Complexes
Jovylyn Gatchalian, Jingwen Liao, Matthew B. Maxwell, et al.
Trends in Immunology (2020) Vol. 41, Iss. 2, pp. 126-140
Open Access | Times Cited: 30
Chemical Inhibitors of a Selective SWI/SNF Function Synergize with ATR Inhibition in Cancer Cell Killing
Emma J. Chory, Jacob G. Kirkland, Chiung-Ying Chang, et al.
ACS Chemical Biology (2020) Vol. 15, Iss. 6, pp. 1685-1696
Open Access | Times Cited: 28
Diversity of small molecule HIV‐1 latency reversing agents identified in low‐ and high‐throughput small molecule screens
Pargol Hashemi, Ivan Sadowski
Medicinal Research Reviews (2019) Vol. 40, Iss. 3, pp. 881-908
Open Access | Times Cited: 27
Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency
Mateusz Stoszko, Abdullah M. S. Al‐Hatmi, Anton Škríba, et al.
Science Advances (2020) Vol. 6, Iss. 33
Open Access | Times Cited: 21
The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy
Henrieke Prins, Raquel Crespo, Cynthia Lungu, et al.
Science Advances (2023) Vol. 9, Iss. 11
Open Access | Times Cited: 7
The Multifaceted Contributions of Chromatin to HIV-1 Integration, Transcription, and Latency
Elisa De Crignis, Tokameh Mahmoudi
International review of cell and molecular biology (2016), pp. 197-252
Closed Access | Times Cited: 18
Fine-tuning of noise in gene expression with nucleosome remodeling
Melina R. Megaridis, Yiyang Lu, Erin N. Tevonian, et al.
APL Bioengineering (2018) Vol. 2, Iss. 2
Open Access | Times Cited: 17
Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents
Enrico Ne, Raquel Crespo, Ray Izquierdo-Lara, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 10, pp. 5577-5598
Open Access | Times Cited: 9
CHD1L Promotes Neuronal Differentiation in Human Embryonic Stem Cells by Upregulating PAX6
Dandan Dou, Hao Zhao, Zili Li, et al.
Stem Cells and Development (2017) Vol. 26, Iss. 22, pp. 1626-1636
Closed Access | Times Cited: 14
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy
Ilaria Vicenti, Filippo Dragoni, Alessia Giannini, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
HIV cure strategies: which ones are appropriate for Africa?
Christopher Zaab-Yen Abana, Helena Lamptey, Evelyn Yayra Bonney, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top